Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary extracted from

  • Shi, W.; Ma, H.; Duan, Y.; Aubart, K.; Fang, Y.; Zonis, R.; Yang, L.; Hu, W.
    Design, synthesis and antibacterial activity of 3-methylenepyrrolidine formyl hydroxyamino derivatives as novel peptide deformylase inhibitors (2011), Bioorg. Med. Chem. Lett., 21, 1060-1063.
    View publication on PubMed

Inhibitors

EC Number Inhibitors Comment Organism Structure
3.5.1.88 1-(2-[[formyl(hydroxy)amino]methyl]hexanoyl)-4-methylidene-N,N-dimorpholin-4-yl-L-prolinamide
-
 Staphylococcus aureus
3.5.1.88 1-(2-[[formyl(hydroxy)amino]methyl]hexanoyl)-4-methylidene-N,N-dimorpholin-4-yl-L-prolinamide
-
 Staphylococcus epidermidis
3.5.1.88 1-(3-cyclopentyl-2-[[formyl(hydroxy)amino]methyl]propanoyl)-4-methylidene-N,N-dimorpholin-4-yl-L-prolinamide
-
 Staphylococcus aureus
3.5.1.88 1-(3-cyclopentyl-2-[[formyl(hydroxy)amino]methyl]propanoyl)-4-methylidene-N,N-dimorpholin-4-yl-L-prolinamide
-
 Staphylococcus epidermidis
3.5.1.88 actinonin
-
 Staphylococcus aureus
3.5.1.88 actinonin
-
 Staphylococcus epidermidis
3.5.1.88 BB-83698
-
 Staphylococcus aureus
3.5.1.88 BB83698
-
 Staphylococcus aureus
3.5.1.88 BB83698
-
 Staphylococcus epidermidis
3.5.1.88 Ciprofloxacin
-
 Staphylococcus aureus
3.5.1.88 Ciprofloxacin
-
 Staphylococcus epidermidis
3.5.1.88 LBM415
-
 Staphylococcus aureus
3.5.1.88 LBM415
-
 Staphylococcus epidermidis
3.5.1.88 linezolid
-
 Staphylococcus aureus
3.5.1.88 linezolid
-
 Staphylococcus epidermidis
3.5.1.88 N-(2-[[(2S)-2-[[1,3-bis(4-fluorophenyl)triazan-2-yl]carbonyl]-4-methylidenepyrrolidin-1-yl]carbonyl]hexyl)-N-hydroxyformamide
-
 Staphylococcus aureus
3.5.1.88 N-(2-[[(2S)-2-[[1,3-bis(4-fluorophenyl)triazan-2-yl]carbonyl]-4-methylidenepyrrolidin-1-yl]carbonyl]hexyl)-N-hydroxyformamide
-
 Staphylococcus epidermidis
3.5.1.88 N-(2-[[(2S)-2-[[1,3-bis(4-hydroxyphenyl)triazan-2-yl]carbonyl]-4-methylidenepyrrolidin-1-yl]carbonyl]hexyl)-N-hydroxyformamide
-
 Staphylococcus aureus
3.5.1.88 N-(2-[[(2S)-2-[[1,3-bis(4-hydroxyphenyl)triazan-2-yl]carbonyl]-4-methylidenepyrrolidin-1-yl]carbonyl]hexyl)-N-hydroxyformamide
-
 Staphylococcus epidermidis
3.5.1.88 N-(2-[[(2S)-2-[[1,3-bis(5-fluoro-1-oxidopyridin-2-yl)triazan-2-yl]carbonyl]-4-methylidenepyrrolidin-1-yl]carbonyl]hexyl)-N-hydroxyformamide
-
 Staphylococcus aureus
3.5.1.88 N-(2-[[(2S)-2-[[1,3-bis(5-fluoro-1-oxidopyridin-2-yl)triazan-2-yl]carbonyl]-4-methylidenepyrrolidin-1-yl]carbonyl]hexyl)-N-hydroxyformamide
-
 Staphylococcus epidermidis
3.5.1.88 N-(2-[[(2S)-2-[[1,3-bis(5-fluoropyridin-2-yl)triazan-2-yl]carbonyl]-4-methylidenepyrrolidin-1-yl]carbonyl]hexyl)-N-hydroxyformamide
-
 Staphylococcus aureus
3.5.1.88 N-(2-[[(2S)-2-[[1,3-bis(5-fluoropyridin-2-yl)triazan-2-yl]carbonyl]-4-methylidenepyrrolidin-1-yl]carbonyl]hexyl)-N-hydroxyformamide
-
 Staphylococcus epidermidis
3.5.1.88 N-(2-[[(2S)-2-[[1,3-bis(5-methyl-1,3-thiazol-2-yl)triazan-2-yl]carbonyl]-4-methylidenepyrrolidin-1-yl]carbonyl]hexyl)-N-hydroxyformamide
-
 Staphylococcus aureus
3.5.1.88 N-(2-[[(2S)-2-[[1,3-bis(5-methyl-1,3-thiazol-2-yl)triazan-2-yl]carbonyl]-4-methylidenepyrrolidin-1-yl]carbonyl]hexyl)-N-hydroxyformamide
-
 Staphylococcus epidermidis
3.5.1.88 N-[2-(cyclopentylmethyl)-3-[(2S)-2-[(1,3-dicyclopropyltriazan-2-yl)carbonyl]-4-methylidenepyrrolidin-1-yl]-3-oxopropyl]-N-hydroxyformamide
-
 Staphylococcus aureus
3.5.1.88 N-[2-(cyclopentylmethyl)-3-[(2S)-2-[(1,3-dicyclopropyltriazan-2-yl)carbonyl]-4-methylidenepyrrolidin-1-yl]-3-oxopropyl]-N-hydroxyformamide
-
 Staphylococcus epidermidis
3.5.1.88 N-[2-([(2S)-2-[(1,3-diphenyltriazan-2-yl)carbonyl]-4-methylidenepyrrolidin-1-yl]carbonyl)hexyl]-N-hydroxyformamide
-
 Staphylococcus aureus
3.5.1.88 N-[2-([(2S)-2-[(1,3-diphenyltriazan-2-yl)carbonyl]-4-methylidenepyrrolidin-1-yl]carbonyl)hexyl]-N-hydroxyformamide
-
 Staphylococcus epidermidis
3.5.1.88 N-[3-[(2S)-2-[[1,3-bis(4-fluorophenyl)triazan-2-yl]carbonyl]-4-methylidenepyrrolidin-1-yl]-2-(cyclopentylmethyl)-3-oxopropyl]-N-hydroxyformamide
-
 Staphylococcus aureus
3.5.1.88 N-[3-[(2S)-2-[[1,3-bis(4-fluorophenyl)triazan-2-yl]carbonyl]-4-methylidenepyrrolidin-1-yl]-2-(cyclopentylmethyl)-3-oxopropyl]-N-hydroxyformamide
-
 Staphylococcus epidermidis
3.5.1.88 N-[3-[(2S)-2-[[1,3-bis(5-fluoro-1-oxidopyridin-2-yl)triazan-2-yl]carbonyl]-4-methylidenepyrrolidin-1-yl]-2-(cyclopentylmethyl)-3-oxopropyl]-N-hydroxyformamide
-
 Staphylococcus aureus
3.5.1.88 N-[3-[(2S)-2-[[1,3-bis(5-fluoro-1-oxidopyridin-2-yl)triazan-2-yl]carbonyl]-4-methylidenepyrrolidin-1-yl]-2-(cyclopentylmethyl)-3-oxopropyl]-N-hydroxyformamide
-
 Staphylococcus epidermidis
3.5.1.88 N-[3-[(2S)-2-[[1,3-bis(5-fluoropyridin-2-yl)triazan-2-yl]carbonyl]-4-methylidenepyrrolidin-1-yl]-2-(cyclopentylmethyl)-3-oxopropyl]-N-hydroxyformamide
-
 Staphylococcus aureus
3.5.1.88 N-[3-[(2S)-2-[[1,3-bis(5-fluoropyridin-2-yl)triazan-2-yl]carbonyl]-4-methylidenepyrrolidin-1-yl]-2-(cyclopentylmethyl)-3-oxopropyl]-N-hydroxyformamide
-
 Staphylococcus epidermidis
3.5.1.88 N-[3-[(2S)-2-[[1,3-bis(5-methyl-1,3-thiazol-2-yl)triazan-2-yl]carbonyl]-4-methylidenepyrrolidin-1-yl]-2-(cyclopentylmethyl)-3-oxopropyl]-N-hydroxyformamide
-
 Staphylococcus aureus
3.5.1.88 N-[3-[(2S)-2-[[1,3-bis(5-methyl-1,3-thiazol-2-yl)triazan-2-yl]carbonyl]-4-methylidenepyrrolidin-1-yl]-2-(cyclopentylmethyl)-3-oxopropyl]-N-hydroxyformamide
-
 Staphylococcus epidermidis
3.5.1.88 penicillin
-
 Staphylococcus aureus
3.5.1.88 penicillin
-
 Staphylococcus epidermidis
3.5.1.88 Vancomycin
-
 Staphylococcus aureus
3.5.1.88 Vancomycin
-
 Staphylococcus epidermidis

Organism

EC Number Organism UniProt Comment Textmining
3.5.1.88 Staphylococcus aureus
-
-
-
3.5.1.88 Staphylococcus aureus ATCC 25923
-
-
-
3.5.1.88 Staphylococcus aureus ATCC 29213
-
-
-
3.5.1.88 Staphylococcus aureus ATCC 43300
-
-
-
3.5.1.88 Staphylococcus epidermidis
-
-
-
3.5.1.88 Staphylococcus epidermidis ATCC 12228
-
-
-

Synonyms

EC Number Synonyms Comment Organism
3.5.1.88 PDF
-
 Staphylococcus aureus
3.5.1.88 PDF
-
 Staphylococcus epidermidis